Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: CERC-801 |
Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI
|
Galactose kinase (GALK1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0417
DME Info
|
Uniprot ID |
|
Interaction Name |
GALK1-gap interaction |
[1], [2] |
Description |
The interaction, between human Galactose kinase and Glyceraldehyde-3-phosphate dehydrogenase from Lactobacillus acidophilus which collectively metabolize the drug CERC-801, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Sulfotransferase 1A1 (SULT1A1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0008
DME Info
|
Uniprot ID |
|
Interaction Name |
SULT1A1-gap interaction |
[1], [4] |
Description |
The interaction, between human Sulfotransferase 1A1 and Glyceraldehyde-3-phosphate dehydrogenase from Lactobacillus acidophilus which collectively metabolize the drug CERC-801, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: NA-alpha-D-glucosamine |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Phosphoglucomutase 3 (PGM3) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0536
DME Info
|
Uniprot ID |
|
Interaction Name |
PGM3-gap interaction |
[1], [3] |
Description |
The interaction, between human Phosphoglucomutase 3 and Glyceraldehyde-3-phosphate dehydrogenase from Lactobacillus acidophilus which collectively metabolize the drug NA-alpha-D-glucosamine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|